Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00378638
Status:
UNKNOWN
Last Update Posted:
2007-10-24
First Post:
2006-09-18
Brief Title:
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer A Pilot Study
Sponsor:
Chap Linnea I MD
Organization:
Chap Linnea I MD
Organization Data
Organization:
Chap Linnea I MD
Class:
INDIV
Study ID:
AVF3359s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chap Linnea I MD
Lead Sponsor Class:
INDIV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |